The Prism Conformity Trial for Post-Traumatic Stress Disorder in Adolescents

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Post-Traumatic Stress Disorder in Adolescence
Interventions
DEVICE

Prism

Prism is using an amygdala-fMRI-guided model for processing EEG signals. The model, termed EEG fMRI pattern (EFP), uses several electrodes EEG-signal to produce a real time amygdala-EFP biomarker signal. GrayMatters' product, Prism, is used to train patients in downregulating the amygdala-derived-EFP biomarker during therapy sessions.

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
lead

GrayMatters Health Ltd.

INDUSTRY

NCT06854328 - The Prism Conformity Trial for Post-Traumatic Stress Disorder in Adolescents | Biotech Hunter | Biotech Hunter